Product Description:
It is Indicated for the treatment of Idiopathic Pulmonary Fibrosis (IPF).
Indicated in combination with docetaxel for the treatment of adult patients with locally advanced, metastatic or recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after first line chemotherapy.






Reviews
There are no reviews yet.